Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
2. Nvp-qaw039
1. 872365-14-5
2. Nvp-qaw039
3. Qaw039
4. Fevipiprant [inn]
5. 2pex5n7dq4
6. Fevipiprant(nvp-qaw039)
7. Qaw-039
8. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic Acid
9. (1-(4-((methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
10. 2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
11. 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
12. 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1h-pyrrolo[2,3-b]pyridine-3-acetic Acid
13. Fevipiprant [usan:inn]
14. Unii-2pex5n7dq4
15. Qaw 039
16. Fevipiprant [jan]
17. Fevipiprant [usan]
18. Fevipiprant [who-dd]
19. Fevipiprant (jan/usan/inn)
20. Gtpl8995
21. Schembl1940595
22. Chembl3137332
23. Dtxsid501336031
24. Hms3743e19
25. Bcp25015
26. Ex-a2495
27. Bdbm50233520
28. Mfcd22548206
29. Zinc43101772
30. Ab85348
31. Cs-5956
32. Db12011
33. Fevipiprant; Nvp-qaw039; Qaw039
34. Sb16897
35. Ac-31956
36. As-74870
37. Hy-16768
38. Ds-022511
39. Ft-0774596
40. D10631
41. Q27077292
42. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid
43. (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
44. [1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-acetic Acid
45. [2-methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]acetic Acid
46. 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid
47. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic Acid
48. Fsy
| Molecular Weight | 426.4 g/mol |
|---|---|
| Molecular Formula | C19H17F3N2O4S |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 426.08611269 g/mol |
| Monoisotopic Mass | 426.08611269 g/mol |
| Topological Polar Surface Area | 97.6 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 709 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of asthma
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
78
PharmaCompass offers a list of Fevipiprant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fevipiprant manufacturer or Fevipiprant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fevipiprant manufacturer or Fevipiprant supplier.
PharmaCompass also assists you with knowing the Fevipiprant API Price utilized in the formulation of products. Fevipiprant API Price is not always fixed or binding as the Fevipiprant Price is obtained through a variety of data sources. The Fevipiprant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fevipiprant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fevipiprant, including repackagers and relabelers. The FDA regulates Fevipiprant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fevipiprant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fevipiprant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fevipiprant supplier is an individual or a company that provides Fevipiprant active pharmaceutical ingredient (API) or Fevipiprant finished formulations upon request. The Fevipiprant suppliers may include Fevipiprant API manufacturers, exporters, distributors and traders.
click here to find a list of Fevipiprant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Fevipiprant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fevipiprant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fevipiprant GMP manufacturer or Fevipiprant GMP API supplier for your needs.
A Fevipiprant CoA (Certificate of Analysis) is a formal document that attests to Fevipiprant's compliance with Fevipiprant specifications and serves as a tool for batch-level quality control.
Fevipiprant CoA mostly includes findings from lab analyses of a specific batch. For each Fevipiprant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fevipiprant may be tested according to a variety of international standards, such as European Pharmacopoeia (Fevipiprant EP), Fevipiprant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fevipiprant USP).
